Recent Updates
Recently added Catalysts
NSPR Positive Sentiment

InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference

Wednesday, April 1, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: InspireMD, Inc. (Nasdaq: NSPR) will present at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026. The event will feature a live audio webcast available on the company's investor page. InspireMD aims to set a standard in carotid stenting with its CGuard®Prime system, enhancing stroke prevention.
Price reaction · baseline $1.63 (2026-03-31 close) · hit pre-market · clean, no other NSPR news in the window
day 0 close · peak
-3.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • InspireMD is participating in a notable healthcare conference.
  • The company is focused on advancing carotid stenting technology.
  • Live audio webcast will provide accessibility for investors.

Full Press Release Details

MIAMI, March 31, 2026(GLOBE NEWSWIRE)-- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard®Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming 25th Annual Needham Virtual Healthcare Conference on Tuesday, April 14that 12:45 pm Eastern Time (ET).
A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD’s corporate website at https://investors.inspiremd.com.
About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contacts:Webb CampbellGilmartin Group LLCwebb@gilmartinir.cominvestor-relations@inspiremd.com

Frequently Asked Questions

When will InspireMD present at the conference?

InspireMD will present on April 14, 2026, at 12:45 pm ET.

How can investors access the conference presentation?

Investors can access the presentation via a live audio webcast on InspireMD's investor page.

What technology does InspireMD focus on?

InspireMD focuses on its CGuard®Prime carotid stent system for stroke prevention.

Where is InspireMD's stock listed?

InspireMD's common stock is listed on Nasdaq under the ticker symbol NSPR.

ShareAdd on Google
Tags: NSPR Viatris Investor Conferences Healthcare InspireMD Needham Conference carotid stent healthcare
Last updated: Apr 1, 2026

Biotech snapshot

Cash runway
$30M liquidity · $4M/mo burn
~8 mo
Medium dilution risk